1. Home
  2. TBLA vs CDNA Comparison

TBLA vs CDNA Comparison

Compare TBLA & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$4.93

Market Cap

952.2M

Sector

Technology

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$21.74

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
CDNA
Founded
2007
1998
Country
United States
United States
Employees
2000
N/A
Industry
Computer Software: Programming Data Processing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
952.2M
1.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
TBLA
CDNA
Price
$4.93
$21.74
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$5.00
$28.00
AVG Volume (30 Days)
2.9M
652.5K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$48,324,000.00
Revenue This Year
$7.63
$16.01
Revenue Next Year
$5.25
$11.31
P/E Ratio
$42.36
$429.80
Revenue Growth
N/A
18.93
52 Week Low
$2.84
$10.96
52 Week High
$5.26
$23.24

Technical Indicators

Market Signals
Indicator
TBLA
CDNA
Relative Strength Index (RSI) 68.93 59.06
Support Level $3.86 $15.80
Resistance Level $5.26 $22.89
Average True Range (ATR) 0.26 1.00
MACD -0.02 -0.06
Stochastic Oscillator 77.26 76.54

Price Performance

Historical Comparison
TBLA
CDNA

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: